MARC Record from marc_columbia

LEADER: 03475cam a22004098a 4500
001 5262489
005 20050927120529.0
008 030617s2004 dcu 000 0 eng
015 $aGBA3-W5168
020 $a1862031509
020 $a1862031495 (pbk.) :$c£22.95
035 $a(OCoLC)ocm52486093
035 $a(NNC)5262489
040 $aUKM$cUKM$dOCLCQ$dNNC-M$dOrLoB-B
043 $ad------
049 $aZCUA
082 04 $a338.436151091724$221
245 00 $aDelivering essential medicines :$bthe way forward /$cedited by Amir Attaran, Brigitte Granville.
260 $aWashington, D.C. :$bBrookings Institution ;$aBristol :$bUniversity Presses Marketing,$c2004.
300 $axvi, 192 p. ;$c24 cm.
505 00 $g1.$tWhy do the poor lack access to essential medicines? /$rLouisiana Lush -- $g2.$tFrom health to wealth and back to health /$rAlexander S. Preker -- $g3.$tResponding to health crises : the frustrations of a small African country /$rAnne C. Conroy, Justin C. Malewezi, Bizwick Mwale and Richard Pendame -- $g4.$tEconomic regulatory frameworks for the pharmaceutical sector in middle-income countries /$rJim Attridge and Rifat Atun -- $g5.$tJoint public-private initiatives and developing-country health systems /$rAnnie Heaton -- $g6.$tPartnership for action : the experience of the Accelerating Access Initiative, 2000-04, and lessons learned /$rJeffrey L. Sturchio -- $g7.$tNon-profit drug distribution : the experience of the International Dispensary Association /$rHenk den Besten and Joseph Gonzi -- $g8.$tUnderstanding patents and out-licensing in the procurement of anti-retroviral medicines /$rAmir Attaran -- $g9.$tWho needs to do what? /$rAmir Attaran and Brigitte Granville.
520 1 $a"Making essential medicines available in developing countries is a pressing international problem. Behind the humanitarian urgency lie longer-term economic, cultural and even geopolitical challenges. Following up on The Economics of Essential Medicines (2002), this volume extends the debate on the best practical ways of improving access to health care and the delivery of health services. While there have been encouraging signs of increased attention to these issues by public policy-makers in rich countries - such as the recent EU initiative to allow the export of generic drugs to poor countries - huge unsolved problems remain. These are addressed by a wide range of contributors - academics and policy-makers from both rich and poor countries, alongside representatives of NGOs and the pharmaceutical sector. Through a combination of detailed thematic and case studies, this volume aims to show the most promising ways forward to ensure essential medicines become accessible to all."--BOOK JACKET.
650 0 $aMedicines, Specific$zDeveloping countries.
650 0 $aMedicines, Specific$xEconomic aspects$zDeveloping countries.
650 0 $aMedical supplies$zDeveloping countries.
650 0 $aMedical supplies$xEconomic aspects$zDeveloping countries.
650 0 $aMedical care$zDeveloping countries.
650 0 $aMedical economics$zDeveloping countries.
650 0 $aMedical policy$zDeveloping countries.
650 12 $aDrugs, Essential$xeconomics.
650 22 $aDrugs, Essential$xsupply & distribution.
650 22 $aHealth Services Accessibility$xeconomics.
650 22 $aHealth Policy.
650 22 $aDeveloping Countries.
700 1 $aAttaran, Amir.
700 1 $aGranville, Brigitte.
852 00 $boff,hsl$hRA401.A5$iD44 2004